Don’t undermine the system that incentivized GLP-1 development
A left-leaning group recently sent a letter to Health and Human Services Secretary Robert F. Kennedy Jr. asking his agency to rescind the patent rights earned by the developers of GLP-1 drugs.
16 Mar 20:04 · The Washington Times